The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
Abstract
CONTEXT: Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11,000 hospitalizations, and 100 deaths every year. OBJECTIVE: To examine population-based disease surveillance data in 3 communities to document the impact of the varicella vaccination program. DESIGN, SETTING, AND SUBJECTS: Active surveillance for varicella conducted among the populations of Antelope Valley, Calif; Travis County, Tex; and West Philadelphia, Pa; from January 1, 1995, to December 31, 2000. Reporting sites included child care centers, schools, universities, physicians, public health clinics, hospitals, emergency departments, and households. MAIN OUTCOME MEASURES: Trends in number and rate of varicella cases and hospitalizations; varicella vaccine coverage. RESULTS: From 1995 through 1998, in each surveillance area, the number of verified varicella cases varied from year to year with marked springtime seasonality. In 1999, the number and rates of varicella cases and hospitalizations declined markedly. From 1995 through 2000, in Antelope Valley, Travis County, and West Philadelphia, varicella cases declined 71%, 84%, and 79%, respectively. Cases declined to the greatest extent among children aged 1 to 4 years, but cases declined in all age groups, including infants and adults. In the combined 3 surveillance areas, hospitalizations due to varicella declined from a range of 2.7 to 4.2 per 100,000 population in 1995 through 1998 to 0.6 and 1.5 per 100,000 population in 1999 and 2000, respectively (P =.15). By 2000, vaccine coverage among children aged 19 to 35 months was 82.1%, 73.6%, and 83.8% in Los Angeles County, Texas, and Philadelphia County, respectively. CONCLUSIONS: Varicella disease has declined dramatically in surveillance areas with moderate vaccine coverage. Continued implementation of existing vaccine policies should lead to further reductions of varicella disease in these communities and throughout the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PUBLIC HEALTH SURVEILLANCE IN THE UNITED STATES
THACKER, S. B., & BERKELMAN, R. L. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036021 · Cited by 767
Population-Based Studies of Varicella Complications
Guess, H. A., Broughton, D. D., Melton, L. J., & Kurland, L. T. (1986) · Pediatrics · doi:10.1542/peds.78.4.723 · Cited by 367
(2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00274-4 · Cited by 284
Varicella Mortality: Trends before Vaccine Licensure in the United States, 1970–1994
Meyer, P. A., Seward, J. F., Jumaan, A. O., & Wharton, M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315714 · Cited by 279
Self-citationThe postmarketing safety profile of varicella vaccine
Sharrar, R. G., LaRussa, P., Galea, S. A., Steinberg, S. P., Sweet, A. R., Keatley, R. M., Wells, M. E., Stephenson, W. P., & Gershon, A. A. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00297-8 · Cited by 253
Postlicensure Safety Surveillance for Varicella Vaccine
Wise, R. P. (2000) · JAMA · doi:10.1001/jama.284.10.1271 · Cited by 213
Hospitalizations for varicella in the United States, 1988 to 1999
GALIL, K., BROWN, C., LIN, F., & SEWARD, J. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00009 · Cited by 202
Self-citationEpidemiologic Methods in Immunization Programs
Chen, R. T., & Orenstein, W. A. (1996) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017931 · Cited by 162
Smith, P. J., Battaglia, M. P., Huggins, V. J., Hoaglin, D. C., Rodén, A.-S., Khare, M., Ezzati-Rice, T. M., & Wright, R. A. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00285-9 · Cited by 159
Committee on Infectious Diseases (2000) · PEDIATRICS · doi:10.1542/peds.105.1.136 · Cited by 126
Cited by
Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
(1996) · PsycEXTRA Dataset · doi:10.1037/e547262006-001 · Cited by 1,079
Varicella zoster virus infection
Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.16 · Cited by 910
Self-citationHeininger, U., & Seward, J. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69561-5 · Cited by 564
Self-citationHerpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
LIESEGANG, T. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 471
Glaser, C. A., Gilliam, S., Schnurr, D., Forghani, B., Honarmand, S., Khetsuriani, N., Fischer, M., Cossen, C. K., & Anderson, L. J. (2003) · Clinical Infectious Diseases · doi:10.1086/367841 · Cited by 434
Metadata
- Authors
- Seward, J. F.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-02-06
- Volume
- 287
- Issue
- 5
- Pages
- 606
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2161014948
- Cited by
- 557
- References
- 13
- FWCI
- 31.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000. https://app.cochat.ai/papers/10.1001/jama.287.5.606
- The paper
- Seward, J. F. (2002). Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000. JAMA. https://doi.org/10.1001/jama.287.5.606
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.